Common Contracts

Contract

October 16th, 2017

• Filed
  October 16th, 2017

AMENDMENT 1 AND ASSIGNMENT DODATEK 1 A POSTOUPENÍ TO SMLOUVY CLINICAL TRIAL AGREEMENT O PROVEDENÍ KLINICKÉHO HODNOCENÍ This Amendment 1 and Assignment (the “Amendment 1 and Assignment”) to the Clinical Trial Agreement is made effective as of its publication in the Contracts Register (the “Amendment Effective Date”), by and between/among: Tento Dodatek 1 a postoupení („Dodatek 1 a postoupení“) Smlouvy o provedení klinického hodnocení nabývá účinnosti dnem zveřejnění v registru smluv („datum účinnosti Dodatku“) a uzavírá se mezi: Convergence Pharmaceuticals Limited, located at Innovation House, 70 Norden Road, Maidenhead, Berkshire, SL6 4AY, United Kingdom (together with its subsidiaries and affiliates, “Convergence”), a wholly owned subsidiary and affiliate of Biogen since 2015, and společností Convergence Pharmaceuticals Limited, se sídlem Innovation House, 70 Norden Road, Maidenhead, Berkshire, SL6 4AY, Spojené království (společně s dceřinými a partnerskými společnostmi dále jen „spo